Albert Labs International Corp. (CNSX: ABRT)
Health Care · Biotechnology · CA
CA$—
— today · — 1Y
Albert Labs International Corp. (CNSX: ABRT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $271.79K.
trading between 0.01 and 0.04.
Tweenvest scores Albert Labs International Corp. across four factors: quality 11/100, value 65/100. Its strongest factor is value.
ABRT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $271.79K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- 2.08
- 52-week high
- CA$0.04
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 74.41M
- Employees
- —
- Next earnings
- —
About Albert Labs International Corp.
Albert Labs International Corp. is a pharmaceutical research and development company dedicated to addressing urgent and underserved patient needs, particularly in critical mental health. The firm specializes in creating psilocybin-assisted therapies aimed at improving conditions such as anxiety, depression, and the psychological distress linked to cancer. This enterprise operates out of Burnaby, Canada.
- ISIN
- CA0127841041
- Listed since
- Feb 1, 2023
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Longevity Health Holdings, Inc.OTCPK: XAGE | $305.70K | $0.12 | -20.88% |
| ChitogenX Inc.CNSX: CHGX | $303.81K | CA$— | — |
| bioXXmed AGDB: T5O | $275.38K | €0.90 | -16.67% |
| NKGen Biotech, Inc.OTCPK: NKGN | $274.26K | $0.00 | -82.50% |
| Oxurion NVENXTBR: OXUR | $253.43K | €0.00 | -25.00% |
| Many Bright Ideas Technologies Inc.TSXV: MBI.H | $248.01K | CA$— | — |
| Chimeric Therapeutics LimitedASX: CHM | $246.44K | AU$0.00 | -40.00% |
| WPD Pharmaceuticals Inc.CNSX: WBIO | $233.63K | CA$— | — |
Figures last refreshed Oct 4, 2026.